Overview

A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency

Status:
Completed
Trial end date:
2016-12-09
Target enrollment:
Participant gender:
Summary
The purpose of the study is to monitor initiated DiaferĀ® therapy administered according to hospital practice and the product labeling in routine clinical practice in haemodialysis patients with Chronic Kidney Disease.
Details
Lead Sponsor:
Pharmacosmos A/S
Collaborator:
BioStata
Treatments:
Ferric Compounds
Iron
Iron isomaltoside 1000